David Darling has a dig at DHB delays

David Darling has a dig at DHB delays
David Darling: Disappointed with slow adoption (Image: Supplied)
Brent Melville
Pacific Edge’s cancer diagnostic products have made headway into the US healthcare sector over the past several years, but many New Zealand patients continue to be shut out by the bureaucracy of local DHBs, the company says.Last June, the NZX-listed firm announced giant US healthcare group Kaiser Permanente had approved its Cxbladder products for use by urologists to monitor patients for bladder cancer. A month later it announced Cxbladder tests will be covered by the Centers for Medicare and Medicaid Services (CMS) across the US mar...

More Markets

Todd Corporation: the reset
Finance

Todd Corporation: the reset

Legacy gas assets will give way to a focus on solar electricity generation.

Kiwibank won't bring banking Revolut-ion
Finance

Kiwibank won't bring banking Revolut-ion

Forget Kiwibank. Revolut is the force big banks will have to reckon with, expert says.

Protest vote against Tony Gibson
Infrastructure

Protest vote against Tony Gibson

The former Port of Auckland boss was reappointed to Marsden Maritime Holdings.

KiwiSaver shakeup in capital markets reform
Markets

KiwiSaver shakeup in capital markets reform

Listing costs may also be reduced if new plans ago ahead.